insights_auto
Why is EMCURE up ४.५७%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३३४.४०
arrow_upward
+४.५७%(+१०२.००) 1D
नोभेम्बर १२, १५:३०:०२ GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,२६०.००
High
₹ २,३४४.४०
Low
₹ २,२४३.६०
Mkt. cap
४.४३ खरब
Avg. vol.
१.९८ लाख
Volume
९.६५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.००
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Stock Market Today: Nvidia Rout Sinks Nasdaq, S&P 500 Futures as Board Weighs Jensen Huang’s Future — CRWV, TTEK, FNV in Focus
Yahoo Finance
·
५३ मिनेट पहिले
What SPDR S&P 500 ETF (SPY) Bought: Apple Leads on Nov. 10
BigGo Finance
·
१ घण्टा पहिले
S&P 500 Has Risen After All 19 Midterm Elections Since 1950, Morgan Stanley Data Show
FXStreet
·
३ घण्टा पहिले
S&P 500: Tech rally offsets post‑CPI selloff – Deutsche Bank
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com